How gene expression affects blood cell function in health and disease
Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
This study is looking at how a specific protein affects the way blood cells called megakaryocytes and platelets work, which is important for blood clotting, and it aims to understand how changes in this process might relate to different diseases, helping to improve treatments for people with blood-related conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oklahoma Medical Research Foundation NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project ID | NIH-11001163 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which gene expression regulation at the translational level influences the behavior of megakaryocytes and platelets, which are crucial for blood clotting. By conducting both basic and clinical investigations in humans and mice, the study aims to uncover how these processes are altered in various diseases. The research focuses on a specific protein, Eukaryotic Initiation Factor 4E (eIF4E), to understand its role in blood cell biology and how it may be affected by disease conditions. The findings could lead to insights into the function of blood cells in health and disease, potentially impacting treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with blood disorders or cardiovascular diseases who are interested in understanding the underlying mechanisms of their conditions.
Not a fit: Patients with non-blood-related conditions or those who do not have any cardiovascular or blood disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for blood disorders and improve understanding of cardiovascular diseases.
How similar studies have performed: While the specific focus on translational control pathways in megakaryocytes is novel, similar approaches have shown promise in other areas of blood research.
Where this research is happening
Oklahoma City, United States
- Oklahoma Medical Research Foundation — Oklahoma City, United States (Active)
Researchers
- Principal investigator: Weyrich, Andrew S — Oklahoma Medical Research Foundation
- Study coordinator: Weyrich, Andrew S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.